Europe registered a 55 percent rise in Covid-19 cases in the last four weeks, despite the availability of vaccines, which should serve as a “warning shot” to other regions, World Health Organization (WHO) officials said on November 4.

Americans are increasingly turning away from the coronavirus and focusing their attention elsewhere – especially toward rising consumer prices and other economic areas where Democrats are less trusted – Reuters/Ipsos polling shows, a shift that could favor Republicans in the 2022 midterm elections.

Covid-19 antibodies passed from infected mothers to their breastfeeding newborns provide more benefit to the baby than researchers expected to see, according to a report published on November 3 in JAMA Network Open. In other research, among people with impaired immune systems, some get less benefit than others from the mRNA Covid-19 vaccines while new data help clarify the differences and supports the need for extra shots.

According to Johns Hopkins University data, as of November 1, there were 5,000,425 Covid-19-related deaths worldwide.

Enrollment in U.S. government-run health insurance program Medicaid during the COVID-19 pandemic grew 16%, with more than 11 million additional Americans signing up, the Department of Health and Human Services said on October 29.

Tedros Adhanom Ghebreyesus, who has steered the global response to the COVID-19 pandemic, is on course to serve a second five-year term as head of the World Health Organization (WHO) after being the only candidate nominated by 28 countries.

Finance and health ministers from the world’s 20 biggest economies (G20) said on Oct. 29 they would take steps to ensure 70 percent of the world’s population is vaccinated against Covid-19 by mid-2022 and created a task force to fight future pandemics.

Texas A&M University Science Center, MD Anderson Cancer Center, and Pulmotect report that the drug PUL-042 appears to work against COVID-19 and other respiratory infections.

Michigan-based Esperion on Oct. 18 announced a plan to reduce the company’s overall workforce by 40 percent and significantly decrease operational expenses in fiscal years 2021 and 2022 to optimize long-term growth.

Veta Health, a leading global provider of digital solutions for remote patient care and chronic condition monitoring, announced that James Sutcliffe was named chief executive officer.